**2.2. Future of ESWL in gall stones treatment**

The lack of sufficient studies for the optimal application of ESWL in patients with gall stones hindered the Food and Drug Administration (FDA) approval for its use for gall stone lithotripsy. However, this did not prevent several medical centers in Europe and Asia to use it for gall stone treatment on a constant rate [9].
